Risk assessment: Situation in northern Africa/Libyan Arab Jamahiriya and the influx of migrants* to Europe
ECDC, after conducting rapid risk assessments, has concluded that the risk of importation of infectious diseases from North Africa to the EU is considered to be low. From a public health perspective, the most urgent concern is related to the poor living conditions of the migrants, such as overcrowding and poor sanitation.
Public health guidance: Seasonal influenza vaccination of children and pregnant women
The aim of this guidance document is to provide EU/EEA Member States and EU bodies with relevant information to make an informed decision on routine vaccination of healthy children and pregnant women with seasonal influenza vaccine. The options presented in this document are based on a systematic review of the literature and the opinions of a group of independent experts.
Mass immunisation campaign in a Roma settled community created an opportunity to estimate its size and measles vaccination uptake, Poland 2009
Stefanoff, P., Orlikova, H., Rogalska, J., Kazanowska-Zielinska, E., Slodzinski, J.
Public health needs of migrants, refugees and asylum seekers in Europe, 2015: Infectious disease aspects
Semenza, J.C., Carrillo-Santisteve, P., Zeller, H., Sandgren, A., Van Der Werf, M.J., Severi, E., Pastore Celentano, L., Wiltshire, E., Suk, J.E., Dinca, I., Noori, T., Kramarz, P.
Review of outbreaks and barriers to MMR vaccination coverage among hard to reach populations in European countries
In recent years, substantial progress had been made towards eliminating measles, mumps and rubella in Europe. Measles vaccine coverage is on the rise and measles cases decreasing in many countries. However, there have still been several large outbreaks of measles, mumps and rubella reported in European countries.
Expert opinion on rotavirus vaccination in infancy
ECDC has published an Expert Opinion on rotavirus vaccination in infancy. The paper provides EU/EEA Member States with relevant scientific information on burden of rotavirus disease, vaccine effectiveness and safety, and cost-effectiveness studies to support the decision-making process on the possible introduction of routine vaccination of children against rotavirus gastroenteritis.